Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | WDR5 | P61964 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27044976 | 0.93 | SMN1; SMN2 (0.36) | HTTSMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL27047534 | 0.92 | LMNA (0.41) | PTGDR2SMN1; SMN2CYP2C19RORCTSHR | |
| SCHEMBL27047555 | 0.92 | PTGDR2 (0.39) | PTGDR2HTTSMN1; SMN2TSHRTDP1 | |
| SCHEMBL3245244 | 0.90 | BCAT1 (0.39) | PTGDR2SMN1; SMN2CYP2C19RORCTSHR | |
| SCHEMBL29452779 | 0.90 | BCAT1 (0.39) | PTGDR2SMN1; SMN2CYP2C19RORCTSHR | |
| SCHEMBL27047561 | 0.88 | BCAT2 (0.42) | PTGDR2HTTSMN1; SMN2 | |
| SCHEMBL27047567 | 0.88 | PTGDR2 (0.43) | PTGDR2CYP2C19RORC | |
| SCHEMBL10577900 | 0.88 | PKM (0.40) | PTGDR2HTTCYP2C19RORCTSHR | |
| SCHEMBL27047548 | 0.87 | PTGDR2 (0.35) | PTGDR2HTTSMN1; SMN2TSHRTDP1 | |
| SCHEMBL7226294 | 0.85 | FFAR1 (0.38) | HTTCYP2C19RORCPPARDPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | PFAS, DDT, NOTUM | PTGDR2 3104/4885HTT 1607/4885SMN1; SMN2 4738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.